Ann: R327 added to WHO List of Antibacterial Products, page-16

@zecs the only phase I/II trial that has been going for any length of time was the burns trial. this was investigator sponsored and therefore beyond RCE 's control. phase I dosing trial for IV dosing has not long concluded and is critical for establishing safety but is not indication specific. each indication will likely need a specific phase II and III trial. the Foot ulcer trial and the uTi trial are all progressing to the next phase in a timely manner. what were your expectations? drugs on average take 10 years and a billion dollars to get approved. RCE is well short of that